Your browser doesn't support javascript.
loading
Pancreatic cancer is associated with medication changes prior to clinical diagnosis.
Zhang, Yin; Wang, Qiao-Li; Yuan, Chen; Lee, Alice A; Babic, Ana; Ng, Kimmie; Perez, Kimberly; Nowak, Jonathan A; Lagergren, Jesper; Stampfer, Meir J; Giovannucci, Edward L; Sander, Chris; Rosenthal, Michael H; Kraft, Peter; Wolpin, Brian M.
Afiliação
  • Zhang Y; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Wang QL; Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
  • Yuan C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Lee AA; Department of Clinical Science, Intervention and Technology, Karolinka Institutet, Stockholm, Sweden.
  • Babic A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Ng K; Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Perez K; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Nowak JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Lagergren J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Stampfer MJ; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Giovannucci EL; Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Sander C; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Rosenthal MH; Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
  • Kraft P; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Wolpin BM; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Nat Commun ; 14(1): 2437, 2023 04 28.
Article em En | MEDLINE | ID: mdl-37117188
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos